Data pooling and analysis to build a preliminary item bank - An example using bowel function in prostate cancer

被引:3
|
作者
Eton, DT [1 ]
Lai, JS
Cella, D
Reeve, BB
Talcott, JA
Clark, JA
McPherson, CP
Litwin, MS
Moinpour, CM
机构
[1] Northwestern Univ, Sch Med, Evanston, IL 60208 USA
[2] NCI, Bethesda, MD 20892 USA
[3] Massachusetts Gen Hosp, Boston, MA 02114 USA
[4] Boston Univ, Sch Publ Hlth, Boston, MA 02215 USA
[5] Univ S Florida, H Lee Moffitt Canc Ctr, Tampa, FL 33682 USA
[6] Univ Calif Los Angeles, Sch Med, Los Angeles, CA 90024 USA
[7] Univ Calif Los Angeles, Sch Publ Hlth, Los Angeles, CA 90024 USA
[8] Fred Hutchinson Canc Res Ctr, Seattle, WA 98104 USA
关键词
bowel function; prostate cancer; quality of life; item response theory; self-report;
D O I
10.1177/0163278705275338
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Assessing bowel function (BF) in prostate cancer can help determine therapeutic trade-offs. We determined the components of BF commonly assessed in prostate cancer studies as an initial step in creating an item bank for clinical and research application. We analyzed six archived data sets representing 4,246 men with prostate cancer. Thirty-one items from validated instruments were available for analysis. Items were classified into domains (diarrhea, rectal urgency, pain, bleeding, bother/distress, and other)then subjected to conventional psychometric and item response theory (IRT) analyses. Items fit the IRT model if the ratio between observed and expected item variance was between 0.60 and 1.40. Four of 31 items had inadequate fit in at least one analysis. Poorly fitting items included bleeding (2), rectal urgency (1), and bother/distress (1). A fifth item assessing hemorrhoids was poorly correlated with other items. Our analyses supported four related components of BF: diarrhea, rectal urgency, pain, and bother/distress.
引用
收藏
页码:142 / 159
页数:18
相关论文
共 50 条
  • [41] The effect of SGLT2 inhibition on prostate cancer Mendelian randomization and observational analysis using electronic healthcare and cohort data
    Zheng, Jie
    Lu, Jieli
    Qi, Jiying
    Yang, Qian
    Zhao, Huiling
    Liu, Haoyu
    Chen, Zhihe
    Huang, Lanhui
    Ye, Youqiong
    Xu, Min
    Xu, Yu
    Wang, Tiange
    Li, Mian
    Zhao, Zhiyun
    Zheng, Ruizhi
    Wang, Shuangyuan
    Lin, Hong
    Hu, Chunyan
    Chui, Celine Sze Ling
    Yeung, Shiu Lun Au
    Luo, Shan
    Dimopoulou, Olympia
    Dixon, Padraig
    Harrison, Sean
    Liu, Yi
    Robinson, Jamie
    Yarmolinsky, James
    Haycock, Philip
    Yuan, Jinqiu
    Lewis, Sarah
    Yuan, Zhongshang
    Gaunt, Tom R.
    Smith, George Davey
    Ning, Guang
    Martin, Richard M.
    Cui, Bin
    Wang, Weiqing
    Bi, Yufang
    CELL REPORTS MEDICINE, 2024, 5 (08)
  • [42] Biomarker Identification through Multiomics Data Analysis of Prostate Cancer Prognostication Using a Deep Learning Model and Similarity Network Fusion
    Wang, Tzu-Hao
    Lee, Cheng-Yang
    Lee, Tzong-Yi
    Huang, Hsien-Da
    Hsu, Justin Bo-Kai
    Chang, Tzu-Hao
    CANCERS, 2021, 13 (11)
  • [43] Trends in the Use of Radiation Therapy for Stage IIA Prostate Cancer From 2004 to 2013: A Retrospective Analysis Using the National Cancer Data Base (NCDB)
    Malouff, T.
    Marsh, S.
    Walters, R. W.
    Silberstein, P.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2016, 96 (02): : E232 - E233
  • [44] The short-term effect of neoadjuvant chemoradiation on anorectal function in rectal cancer: analysis using preoperative manometric data
    Jang, N.
    Han, T.
    Kang, S.
    Kim, D.
    Kim, J.
    EJC SUPPLEMENTS, 2009, 7 (02): : 331 - 331
  • [45] Assessment of late urinary, bowel and sexual function after dose escalation from 70 to 76 Gy using image-guided radiotherapy in curative treatment of prostate cancer
    Haugnes, Hege S.
    Melby, Bianca
    Larsen, Kari M.
    Langdal, Ingrid
    Rasi, Mana
    Bremnes, Roy M.
    SCANDINAVIAN JOURNAL OF UROLOGY AND NEPHROLOGY, 2012, 46 (02): : 124 - 132
  • [46] Development of a predictive model for death amongst patients with Metastatic Hormone Sensitive Prostate Cancer (mHSPC) treated with one of the approved treatment plans, on characteristics present at admission using Big data: Preliminary results from the European network of excellence for big data in prostate cancer (PIONEER)
    Nicoletti, R.
    Gomez Rivas, J.
    Ibanez, L.
    Steinbeisse, C.
    de Meulder, B.
    Ayman, H.
    Golozar, A.
    Snijder, R.
    Van Hemelrijck, M.
    Beyer, K.
    Willemse, P-P.
    Murtola, T.
    Roobol, M. J.
    Moreno-Sierra, J.
    Campi, R.
    Gacci, M.
    Mottet, N.
    Merseburger, A.
    Cornford, P.
    Ndow, J.
    EUROPEAN UROLOGY, 2024, 85 : S1579 - S1580
  • [47] Identifying risk subgroups of invasive prostate cancer surgical delay using a person-centered approach: The constellation of health determinants using latent class analysis on cancer registry data
    Ishino, Francisco Alejandro Montiel
    Liu, Xiaohui
    Salmeron, Bonita
    Das, Rina
    Williams, Faustine
    CANCER RESEARCH, 2020, 80 (16)
  • [48] A Critical Analysis of the Tumor Volume Threshold for Clinically Insignificant Prostate Cancer Using a Data Set of a Randomized Screening Trial EDITORIAL COMMENT
    Vollmer, Robin T.
    JOURNAL OF UROLOGY, 2011, 185 (01): : 125 - 125
  • [49] Dietary isoflavone intake and lung cancer risk: an analysis using data from the prostate, lung, colorectal, and ovary (PLCO) trial.
    Wang, Qian
    Ru, Meng
    Boffetta, Paolo
    CANCER RESEARCH, 2021, 81 (13)
  • [50] Re: A Critical Analysis of the Tumor Volume Threshold for Clinically Insignificant Prostate Cancer Using a Data Set of a Randomized Screening Trial Reply
    不详
    JOURNAL OF UROLOGY, 2011, 186 (03): : 1159 - 1159